Structured JSON API for this factor page: https://sharemaestro.com/factors/api/tickers/168fd802-fccc-4e50-a2bc-bc539b6e35a1/

AMG

Amgen Inc.
Chart
€307.25
Latest Week 2026-06-05
Snapshot 2026-06-07 · 0.0w · Fresh
0.54
OS Score
17.0%
Value
94.0%
Quality
72.0%
Momentum
7/9
F-Score
0.400
QV
Strategy Eligibility
2 of 23 passing
OS Composite
Trending Value
Quality × Value
🏛
Cornerstone Value
🌿
Cornerstone Growth
💎
Deep Value
VC2 Cheapest
📐
EBITDA/EV
Veiled Value
Piotroski Bargains
🔬
Quality Compounders
📈
Consistent Earners
🌱
GARP
🔄
Shareholder Yield
3.1%
💰
High Yield
Div 3.1%
🚀
Momentum Leaders
Market Leaders
Tiny Titans
🔍
Small Cap Value
🛡
Low Volatility
🏷
Sector Cheapest
🧠
Capital Allocators
Risk-Adj Momentum
V
Value Analysis
Cheapness relative to fundamentals
17.0%ile
P/E
21.3×
P/S
4.5×
P/B
18.0×
E/P
0.0470
FCF Yield
0.041
EBITDA/EV
0.079
SH Yield
0.031
Relative Strength Across Value Dimensions
Multiples & Yields — Decomposition
VC1 (5-Factor)
83.00000000
/100 — 1=cheapest
VC2 (Trending Value)
81.00000000
/100
VC3 (Buyback)
78.00000000
/100
VC2 score of 81.00000000/100 — expensive across all six composite measures.
Q
Quality Analysis
Profitability, efficiency, balance sheet & earnings quality
94.0%ile
ROE
0.849
ROA
0.084
Net Margin
0.210
Op Margin
0.284
GPA
0.275
Current
1.26
F-Score
7/9
Quality Radar — Relative Strength
Profitability & Leverage Breakdown
Rev Growth
0.100
Earn Growth
0.879
Stability
0.399
lower=better
Accruals
-0.032
lower=better
5yr Consist
No
ROE of 85% is exceptional.
M
Momentum & Risk
Price trend, volatility regime, risk-adjusted returns
72.0%ile
6M Return
9.7%
12M Return
24.6%
12-1 Mom
12.4%
Risk-Adj
0.47
Vol 252d
26.5%
Vol 60d
62.0%
↑ Expanding
Max DD 12M
-15.1%
Return Comparison — 6M / 12M / 12-1
Volatility Regime — 60d vs 252d
Near-term vol (62%) is expanding vs long-term (27%) — risk is increasing.
OS
Composite & Factor Heatmap
All factors at a glance
0.54
Pillar Balance — Value / Quality / Momentum
Factor Heatmap — green=strong, red=weak
Sector Context
Healthcare · 79 peers
Sector Value %ile
15.0%
Sector Quality %ile
93.8%
P/E z-score
-0.13
P/B z-score
2.48
Sector Avg OS
49.3%
Ticker vs Sector Averages
Relative Valuation Z-Score
Top Sector Peers (By OS)
SymbolNameOSValueQualityMomentum
MED MEDICLIN Aktiengesellschaft 99.0% 97.0% 83.0% 79.0%
DRW8 Drägerwerk AG & Co. KGaA 96.0% 93.0% 62.0% 78.0%
DRW3 Drägerwerk AG & Co. KGaA 95.0% 85.0% 62.0% 80.0%
AJ91 DocCheck AG 95.0% 82.0% 88.0% 70.0%
CBHD Coloplast A/S 94.0% 98.0% 91.0% 22.0%
M12 M1 Kliniken AG 93.0% 70.0% 89.0% 76.0%
BRM Bristol-Myers Squibb Company 92.0% 61.0% 98.0% 74.0%
NOV Novo Nordisk A/S 91.0% 98.0% 78.0% 20.0%
Factor Interactions
Quality Momentum — Expensive
Strong quality (94th) and momentum (72th) but expensive (17th value). Premium priced — watch for mean reversion.
Quality at a Premium
High quality (94th) but expensive (17th value). Upside may be limited without earnings growth.
Volatility Expanding
60-day vol (62%) significantly exceeds 252-day (27%). Near-term risk is elevated.
Factor Analysis
Comprehensive factor intelligence — strengths, weaknesses & cross-factor profile
Value
D
42.3% avg (7 factors)
Quality
B
68.9% avg (7 factors)
Momentum
C
49.2% avg (4 factors)
Risk
B
72.4% avg (1 factors)
High quality business commanding a premium price. The market recognises the quality — returns from here depend on continued fundamental execution.
▲ Top Strengths — highest scoring factors
▼ Key Weaknesses — lowest scoring factors
Factor Persistence1 snapshots
FactorCurrentStreakTrendSpark
OS Composite0.540—0
Value %ile0.170—1
Quality %ile0.940—1
Momentum %ile0.720—1
F-Score7.000—1
Confidence0.939—1
Volatility0.265—0
Value FactorsCheapness relative to fundamentals — lower multiples = cheaper
P/E Ratio
21.26
Earnings Yield (E/P)
0.0470
Price / Sales
4.46
Price / Book
18.04
Price / Cash Flow
15.42
FCF Yield
4.1%
EBITDA / EV
7.9%
Sales Yield (1/P·S)
0.1763
Shareholder Yield
Div + net buyback / mktcap
3.1%
Quality FactorsProfitability, efficiency, and balance sheet strength
Return on Equity
84.9%
Return on Assets
8.4%
Net Margin
21.0%
Operating Margin
28.4%
Gross Profit / Assets
Novy-Marx GPA
27.5%
Current Ratio
1.26
Accruals Ratio
(NI-OCF)/Assets — lower=better
-0.032
MomentumPrice trend strength over different horizons
6M Return
9.7%
12M Return
24.6%
12-1 Momentum
Jegadeesh-Titman (skip recent month)
12.4%
Risk-Adjusted Momentum
Mom 12-1 ÷ Vol
0.47
Growth & StabilityEarnings trajectory, consistency, and capital allocation
Revenue Growth (YoY)
10.0%
Earnings Growth (YoY)
87.9%
Earnings Stability (CV)
Lower = more stable
0.399
5yr Consistent
EPS up every year for 5 years
No
Piotroski F-Score
7
Dividend Yield
3.1%
Buyback Yield
0.0%
O'Shaughnessy CompositesValue Composites (WWOWS 4th Ed) — 1=cheapest, 100=most expensive
VC1 (5-factor)
P/E+P/S+P/B+P/CF+EBITDA/EV
83
VC2 (6-factor)
VC1 + Shareholder Yield — used for Trending Value
81
VC3 (6-factor)
VC1 + Buyback Yield — no dividend preference
78
Capital Allocation & AlphaAlpha within factors — quality of management decisions
Veiled Value
Expensive by P/B, cheap by everything else
No
Market Leader
Above-avg mcap+revenue, non-utility
No
All Stocks Universe
Market cap > $200M
Yes
Tiny Titan
Micro-cap, low P/S, positive momentum
No
Quarterly Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity
Annual Fundamentals
Revenue
Net Income
FCF
Net Margin
Show all
Op Income
OCF
CapEx
Equity